Strategic Consulting

Benefit-risk Strategy Consulting

PrimeVigilance supports clients in their benefit-risk strategy development.

PrimeVigilance develops and supports development of Benefit-Risk Frameworks for the qualitative assessment of benefit-risk profiles of drugs, and offer services in the selection and execution of appropriate quantitative benefit-risk analysis methods, with hands-on experience in performing Multi-Criteria Decision Analyses (MCDAs) and the conduct of patient and HCP preference studies.

PrimeVigilance’s Human Data Research team provides support in relevant, related evidence generation strategy and designs.

This site uses cookies to personalise and customise your experience. No cookies collect personal or sensitive information. By clicking “I Accept", you consent to cookies in accordance with our cookie policy.